AMEERA-3, a phase 2 trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (her2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies
Küçük Resim Yok
Tarih
2021
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Amer Assoc Cancer Research
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
San Antonio Breast Cancer Virtual Symposium -- DEC 08-11, 2020 -- ELECTR NETWORK
Anahtar Kelimeler
[No Keywords]
Kaynak
Cancer Research
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
81
Sayı
4
